-
Lung Cancer and StigmaClinical health psychologist Jamie Ostroff discusses how feelings of blame surrounding a lung cancer diagnosis affect physical and mental health.
by Jen Tota McGivney
-
April 19: The Week in Cancer NewsThe CRISPR gene-editing technique is used for the first time in a U.S. cancer clinical trial, and a new targeted therapy is approved for advanced bladder cancer.
by Kate Yandell
-
New Rule Would Require Breast Density DisclosureA proposed federal rule says that patients must be informed after mammograms if they have dense breasts.
by Carly Weeks
-
April 12: The Week in Cancer NewsCancer patients report difficulty getting student loans deferred, and new guidelines for breast cancer screening are released.
by Kate Yandell
-
April 5: The Week in Cancer NewsPeople with metastatic cancer call for more research into survivorship issues facing this group, and a study indicates that taking probiotics may interfere with immunotherapy response.
by Marci A. Landsmann and Kate Yandell
-
The Crowded Field of Checkpoint InhibitorsDrug developers behind currently approved checkpoint inhibitors discuss the pros and cons of competition in the field.
by Kate Yandell
-
PARP Inhibitors in Pancreatic CancerDrugs that target DNA repair enzymes may provide alternatives to long-term chemotherapy for some patients with pancreatic cancer.
by Kate Yandell
-
Telling Their Stories Through PostersSurvivors and advocates display their posters alongside the work of thousands of cancer researchers.
by Kevin McLaughlin
-
Drug Costs and Cancer CareExperts discuss the value of cancer treatments in a climate of rising drug prices.
by Kevin McLaughlin
-
What Is Hyper-Progression?Some researchers believe that immunotherapy occasionally causes cancer to grow faster, a phenomenon dubbed hyper-progression.
by Kate Yandell
Adding chemotherapy to targeted therapy improves outcomes for people with advanced EGFR-positive non-small cell lung cancer.
by Sandra Gordon
Lessons From 20 Years Living With CancerMultiple myeloma survivor Jonathan Gluck reflects on uncertainty, and the scientific progress that has kept him living with cancer for more than two decades.
by Eric Fitzsimmons
The Enduring Importance of Cancer Disparities ResearchOpening session from AACR conference highlights how perseverance and adversity have informed cancer disparities research over the years.
by Eric Fitzsimmons
Most Cancer Survivors Don’t Meet Healthy Diet GoalsDespite research linking fruits and vegetables to cancer survival, many people do not change their eating habits after diagnosis.
by Darlene Dobkowski
-
Keeping Hope Alive—Why the Schlueters Rally for Medical ResearchRichard and Michelle Schlueter attended the Rally for Medical Research to advocate for NIH funding after budget cuts delayed his treatment.
-
Cancer in the Rearview Mirror: 15 Years of AACR Cancer Progress Report Survivor StoriesCancer survivors profiled over the past 15 years in the AACR Cancer Progress Reports shared updates on their lives and the progress made against cancer.
Cancer Research at a Crossroads
